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to persons severely affected, development of an effec-
tive vaccine is urgently needed to prevent disease. Until a 
vaccine becomes available, public health authorities will 
need to maintain their focus on surveillance, disease rec-
ognition, implementation of control measures, and public 
education about protective measures.
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From the Greek diphthera (leather), diphtheria is named for the tough pseudomembrane that forms in 
the patient’s throat. One of the earliest accounts of what 
may have been symptoms of diphtheria is found in Hip-
pocrates work Epidemics III, written 2,500 years ago. 
Reports of epidemics of “throat distemper” began to ap-
pear in the 1500s, but before the 19th century, diphtheria 
was known around the world by many different names, 
such as Syrian ulcer, membranous angina, malignant 
croup, and Boulogne sore throat. In 1821, French phy-
sician Pierre Bretonneau described diphtheria’s unique 
clinical characteristics during an epidemic in southern 
France, when he named it diphtérite after the leathery 
texture of the pseudomembrane.
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